Atai Life Sciences schizophrenia drug fails to meet main goal in trial - TradingView

Reuters | July 25, 2025, 4:31 p.m. | Original
Atai Life Sciences schizophrenia drug fails to meet main goal in trial TradingView
Wall Street ends higher, dollar firms ahead of a big week for market risk - Reuters US states to get $608 million from FEMA to build migrant detention centers - Reuters